Overview

• Kodak warned in its Aug. 12 SEC filing that it has “substantial doubt” about its ability to continue as a going concern, citing roughly $500 million of debt due within 12 months and no committed financing.
• The company held $155 million in cash as of June 30 and reported a $26 million net loss for the quarter, intensifying concerns over its cash runway.
• Kodak plans to terminate and revert its U.S. Retirement Income Plan and pursue debt refinancing to unlock pension assets for repayment, aiming for clarity by this Friday and completion by December.
• The new Rochester pharmaceuticals plant is nearing completion for regulated production later this year as part of Kodak’s diversification into pharma ingredients.
• Shares plunged about 20–25 percent after the disclosure, underscoring investor skepticism over Kodak’s financing prospects and survival.